These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 14163294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F, SIBONI K, GODTFREDSEN A, VON MAGNUS.
    Fra Sundhedsstyr; 1963 Oct 18; 125():72-3. PubMed ID: 14095905
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. POLIOVIRUS IN FEBRILE VACCINEES.
    KELLY S, FOX JP, SPIGLAND I.
    Arch Environ Health; 1965 Jan 18; 10():16-20. PubMed ID: 14219480
    [No Abstract] [Full Text] [Related]

  • 5. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F.
    Zentralbl Bakteriol Orig; 1963 Dec 18; 191():112-6. PubMed ID: 14119890
    [No Abstract] [Full Text] [Related]

  • 6. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S, SASATANI M, HAYAKAWA Y, KUROSE T, ASHIHARA Y.
    Shonika Kiyo; 1963 Dec 18; 9():283-96. PubMed ID: 14112921
    [No Abstract] [Full Text] [Related]

  • 7. POLIOMYELITIS IN DUNDEE, 1962.
    WEIR IB, JAMIESON WM, GREEN DM.
    Br Med J; 1964 Oct 03; 2(5413):853-7. PubMed ID: 14185637
    [No Abstract] [Full Text] [Related]

  • 8. [ORAL POLIOMYELITIS VACCINATION. ITS PRINCIPLE, USES AND METHODS FOR EXPLAINING POSSIBLE SIDE-EFFECTS].
    HAAS R.
    Hippokrates; 1963 Nov 15; 34():843-51. PubMed ID: 14095927
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EPIDEMIOLOGICAL ASPECTS OF COXSACKIE AND ECHO VIRUS INFECTIONS IN TROPICAL AREAS.
    FOX JP.
    Am J Public Health Nations Health; 1964 Jul 15; 54(7):1134-42. PubMed ID: 14157847
    [No Abstract] [Full Text] [Related]

  • 12. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O, VON METTENHEIM, HOEVEL H.
    Zentralbl Bakteriol Orig; 1964 Feb 15; 192():1-11. PubMed ID: 14176847
    [No Abstract] [Full Text] [Related]

  • 13. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F, SIBONI K, GODTFREDSEN A.
    Acta Pathol Microbiol Scand; 1964 Feb 15; 61():437-45. PubMed ID: 14164891
    [No Abstract] [Full Text] [Related]

  • 14. Paralysis after oral poliomyelitis vaccine.
    HINTON GG, DUNCAN IB, RATHBUN JC.
    Can Med Assoc J; 1962 Oct 27; 87(17):915-6. PubMed ID: 13954690
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O, GUENTHER O.
    Med Welt; 1964 Apr 11; 15():822-31. PubMed ID: 14194499
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE.
    ROCA-GARCIA M, MARKHAM FS, COX HR, VARGAS-MENDEZ O, GUEVARA EC, MONTOYA JA.
    JAMA; 1964 May 18; 188():639-46. PubMed ID: 14121285
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [NATIONAL PROGRAM OF ORAL VACCINATION AGAINST POLIOMYELITIS IN CHILE, 1962].
    RISTORI C, BOCCARDO H, BORGONO JM, MIRANDA M.
    Rev Med Chil; 1964 Jan 18; 92():77-81. PubMed ID: 14148415
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.